Carotid Doppler Peak Velocity Variation in Liposuction Fluid Management

NCT05930106 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-04-23

No results posted yet for this study

Summary

This study aims to compare the hemodynamic parameters, postoperative plethysmography variability index, the total amount of postoperative intravenous fluid administration needed, and the urine output of two methods of fluid resuscitation during liposuction surgery. One method involves using carotid artery Doppler peak velocity variation, while the other is the conventional fluid ratio.

Conditions

  • Lipodystrophy

Interventions

OTHER

Intraoperative fluid ratio

This ratio is calculated by dividing the sum of procedure subcutaneous infiltration and intravenous fluid by the total aspirate volume during surgery

DEVICE

Carotid Artery Doppler Peak Velocity Variation

Patients will be given a fluid maintenance rate of 1.5 ml/kg/h. To determine fluid responsiveness, the carotid artery peak velocity variation (ΔVPeak-CA) will be measured before, during, and after the procedure. If the ΔVPeak-CA goes above 15%, the patient will receive a fluid bolus of lactated ringer solution at a rate of 4-6 ml/kg over 10-15 minutes, and the team will re-measure fluid responsiveness 10 minutes after each ΔVPeaK-CA.

Sponsors & Collaborators

  • TJ Plast Advanced Center for Plastic Surgery

    lead OTHER

Principal Investigators

  • Sergio Soto Hopkins, M.D. · TJ Plast Advanced Center for Plastic Surgery

  • Hector Milla, M.D. · TJ Plast Advanced Center for Plastic Surgery

  • Israel Espino Gaucin, M.D. · TJ Plast Advanced Center for Plastic Surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-20
Primary Completion
2024-11-20
Completion
2024-12-20

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05930106 on ClinicalTrials.gov